CORD-19:16a812de72963ceda960a168236e8dbe91832d45 / 44363-44746 JSONTXT

{"project":"CORD-19-SciBite-sentences","denotations":[{"id":"T570","span":{"begin":0,"end":383},"obj":"https://id.nlm.nih.gov/mesh/D006801"},{"id":"T575","span":{"begin":0,"end":383},"obj":"http://purl.obolibrary.org/obo/GO0043526"},{"id":"T576","span":{"begin":0,"end":383},"obj":"http://purl.obolibrary.org/obo/GO0005488"},{"id":"T579","span":{"begin":0,"end":383},"obj":"https://id.nlm.nih.gov/mesh/D010265"}],"attributes":[{"id":"A570","pred":"class","subj":"T570","obj":"SPECIES"},{"id":"A575","pred":"class","subj":"T575","obj":"GOONTOL"},{"id":"A576","pred":"class","subj":"T576","obj":"GOONTOL"},{"id":"A579","pred":"class","subj":"T579","obj":"INDICATION"}],"text":"Remyelination as Neuroprotection Using oligodendrocyte binding as a screening assay, we identified candidate human monoclonal antibodies that might also promote remyelination (Warrington et al., 2000) . Human monoclonal antibodies were isolated from patients with monoclonal gammopathy, a relatively common condition characterized by high concentrations of monoclonal serum antibody."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T221","span":{"begin":0,"end":202},"obj":"Sentence"},{"id":"T222","span":{"begin":203,"end":383},"obj":"Sentence"}],"text":"Remyelination as Neuroprotection Using oligodendrocyte binding as a screening assay, we identified candidate human monoclonal antibodies that might also promote remyelination (Warrington et al., 2000) . Human monoclonal antibodies were isolated from patients with monoclonal gammopathy, a relatively common condition characterized by high concentrations of monoclonal serum antibody."}

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T221","span":{"begin":0,"end":202},"obj":"Sentence"},{"id":"TextSentencer_T222","span":{"begin":203,"end":383},"obj":"Sentence"},{"id":"TextSentencer_T221","span":{"begin":0,"end":202},"obj":"Sentence"},{"id":"TextSentencer_T222","span":{"begin":203,"end":383},"obj":"Sentence"},{"id":"T75884","span":{"begin":0,"end":202},"obj":"Sentence"},{"id":"T37881","span":{"begin":203,"end":383},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Remyelination as Neuroprotection Using oligodendrocyte binding as a screening assay, we identified candidate human monoclonal antibodies that might also promote remyelination (Warrington et al., 2000) . Human monoclonal antibodies were isolated from patients with monoclonal gammopathy, a relatively common condition characterized by high concentrations of monoclonal serum antibody."}

{"project":"Epistemic_Statements","denotations":[{"id":"T101","span":{"begin":0,"end":202},"obj":"Epistemic_statement"}],"text":"Remyelination as Neuroprotection Using oligodendrocyte binding as a screening assay, we identified candidate human monoclonal antibodies that might also promote remyelination (Warrington et al., 2000) . Human monoclonal antibodies were isolated from patients with monoclonal gammopathy, a relatively common condition characterized by high concentrations of monoclonal serum antibody."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T168","span":{"begin":264,"end":285},"obj":"Disease"}],"attributes":[{"id":"A168","pred":"mondo_id","subj":"T168","obj":"http://purl.obolibrary.org/obo/MONDO_0004960"}],"text":"Remyelination as Neuroprotection Using oligodendrocyte binding as a screening assay, we identified candidate human monoclonal antibodies that might also promote remyelination (Warrington et al., 2000) . Human monoclonal antibodies were isolated from patients with monoclonal gammopathy, a relatively common condition characterized by high concentrations of monoclonal serum antibody."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T107","span":{"begin":368,"end":373},"obj":"Body_part"}],"attributes":[{"id":"A107","pred":"uberon_id","subj":"T107","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"Remyelination as Neuroprotection Using oligodendrocyte binding as a screening assay, we identified candidate human monoclonal antibodies that might also promote remyelination (Warrington et al., 2000) . Human monoclonal antibodies were isolated from patients with monoclonal gammopathy, a relatively common condition characterized by high concentrations of monoclonal serum antibody."}